Manulife (Manufacturers Life Insurance)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $92.3M | Sell |
147,961
-260,970
| -64% | -$178M | 0.07% | 260 |
|
|
2026
Q1 | $316M | Sell |
408,931
-12,298
| -3% | -$9.42M | 0.27% | 75 |
|
|
2025
Q4 | $325M | Buy |
421,229
+40,214
| +11% | +$27.3M | 0.27% | 78 |
|
|
2025
Q3 | $214M | Buy |
381,015
+1,478
| +0.4% | +$836K | 0.18% | 119 |
|
|
2025
Q2 | $199M | Sell |
379,537
-18,699
| -5% | -$10.4M | 0.18% | 119 |
|
|
2025
Q1 | $253M | Buy |
398,236
+41,826
| +12% | +$28.8M | 0.24% | 97 |
|
|
2024
Q4 | $254M | Buy |
356,410
+18,366
| +5% | +$15.4M | 0.22% | 96 |
|
|
2024
Q3 | $355M | Sell |
338,044
-2,522
| -0.7% | -$2.81M | 0.31% | 65 |
|
|
2024
Q2 | $358M | Buy |
340,566
+2,270
| +0.7% | +$2.2M | 0.33% | 62 |
|
|
2024
Q1 | $326M | Sell |
338,296
-1,364
| -0.4% | -$1.3M | 0.3% | 72 |
|
|
2023
Q4 | $298M | Sell |
339,660
-26,314
| -7% | -$21.7M | 0.18% | 97 |
|
|
2023
Q3 | $301M | Buy |
365,974
+1,474
| +0.4% | +$1.16M | 0.18% | 96 |
|
|
2023
Q2 | $262M | Buy |
364,500
+13,635
| +4% | +$10.5M | 0.15% | 116 |
|
|
2023
Q1 | $288M | Buy |
350,865
+5,454
| +2% | +$4.11M | 0.16% | 107 |
|
|
2022
Q4 | $249M | Buy |
345,411
+80,532
| +30% | +$59.4M | 0.16% | 110 |
|
|
2022
Q3 | $183M | Buy |
264,879
+8,379
| +3% | +$5.27M | 0.13% | 126 |
|
|
2022
Q2 | $152M | Buy |
256,500
+5,757
| +2% | +$3.74M | 0.11% | 150 |
|
|
2022
Q1 | $175M | Buy |
250,743
+49,658
| +25% | +$31.4M | 0.11% | 146 |
|
|
2021
Q4 | $128M | Buy |
201,085
+5,969
| +3% | +$3.67M | 0.08% | 199 |
|
|
2021
Q3 | $118M | Buy |
195,116
+93,097
| +91% | +$57.8M | 0.1% | 212 |
|
|
2021
Q2 | $57M | Sell |
102,019
-1,706
| -2% | -$864K | 0.05% | 343 |
|
|
2021
Q1 | $49.1M | Buy |
103,725
+7,217
| +7% | +$3.51M | 0.04% | 374 |
|
|
2020
Q4 | $46.6M | Sell |
96,508
-1,942
| -2% | -$1.05M | 0.04% | 353 |
|
|
2020
Q3 | $55.1M | Sell |
98,450
-9,529
| -9% | -$5.78M | 0.06% | 303 |
|
|
2020
Q2 | $66M | Buy |
107,979
+20,395
| +23% | +$11.6M | 0.06% | 274 |
|
|
2020
Q1 | $42.8M | Buy |
87,584
+11,886
| +16% | +$4.9M | 0.05% | 317 |
|
|
2019
Q4 | $28.4M | Sell |
75,698
-2,110
| -3% | -$710K | 0.03% | 457 |
|
|
2019
Q3 | $21.3M | Buy |
77,808
+2,942
| +4% | +$871K | 0.02% | 537 |
|
|
2019
Q2 | $23.4M | Sell |
74,866
-6,060
| -7% | -$2.02M | 0.03% | 499 |
|
|
2019
Q1 | $33.2M | Buy |
80,926
+2,549
| +3% | +$1.05M | 0.04% | 417 |
|
|
2018
Q4 | $29.3M | Sell |
78,377
-1,741
| -2% | -$637K | 0.04% | 421 |
|
|
2018
Q3 | $32.4M | Sell |
80,118
-3,553
| -4% | -$1.35M | 0.03% | 429 |
|
|
2018
Q2 | $28.9M | Buy |
83,671
+7,410
| +10% | +$2.32M | 0.03% | 483 |
|
|
2018
Q1 | $26.3M | Sell |
76,261
-4,592
| -6% | -$1.6M | 0.03% | 502 |
|
|
2017
Q4 | $30.4M | Sell |
80,853
-5,432
| -6% | -$2.2M | 0.03% | 461 |
|
|
2017
Q3 | $38.6M | Buy |
86,285
+1,308
| +2% | +$622K | 0.05% | 376 |
|
|
2017
Q2 | $41.7M | Buy |
84,977
+1,037
| +1% | +$454K | 0.05% | 350 |
|
|
2017
Q1 | $32.5M | Buy |
83,940
+4,207
| +5% | +$1.56M | 0.04% | 408 |
|
|
2016
Q4 | $29.3M | Buy |
79,733
+3,692
| +5% | +$1.4M | 0.04% | 392 |
|
|
2016
Q3 | $30.6M | Buy |
76,041
+598
| +0.8% | +$240K | 0.05% | 356 |
|
|
2016
Q2 | $26.3M | Buy |
75,443
+2,594
| +4% | +$999K | 0.04% | 374 |
|
|
2016
Q1 | $26.2M | Sell |
72,849
-6,644
| -8% | -$2.74M | 0.02% | 384 |
|
|
2015
Q4 | $43.2M | Sell |
79,493
-1,585
| -2% | -$859K | 0.04% | 270 |
|
|
2015
Q3 | $37.7M | Buy |
81,078
+4,266
| +6% | +$2.29M | 0.04% | 303 |
|
|
2015
Q2 | $39.2M | Buy |
76,812
+482
| +0.6% | +$235K | 0.05% | 283 |
|
|
2015
Q1 | $34.5M | Sell |
76,330
-2,492
| -3% | -$1.06M | 0.04% | 311 |
|
|
2014
Q4 | $32.3M | Buy |
78,822
+2,968
| +4% | +$1.17M | 0.05% | 300 |
|
|
2014
Q3 | $27.3M | Sell |
75,854
-6,503
| -8% | -$2.18M | 0.04% | 343 |
|
|
2014
Q2 | $23.3M | Buy |
82,357
+3,578
| +5% | +$1.06M | 0.04% | 378 |
|
|
2014
Q1 | $23.7M | Buy |
78,779
+1,727
| +2% | +$532K | 0.04% | 383 |
|
|
2013
Q4 | $21.2M | Sell |
77,052
-8,026
| -9% | -$2.31M | 0.03% | 402 |
|
|
2013
Q3 | $26.6M | Buy |
85,078
+4,593
| +6% | +$1.21M | 0.04% | 327 |
|
|
2013
Q2 | $18.1M | Buy |
+80,485
| New | +$18.7M | 0.03% | 392 |
|
Other funds holding REGN
Manulife (Manufacturers Life Insurance)'s REGN Position: Q2 2026 in Review
Manulife (Manufacturers Life Insurance) reduced its Regeneron Pharmaceuticals (REGN) stake by 64% in Q2 2026, selling an estimated $178M and leaving 147,961 shares worth $92.3M. The position accounts for 0.07% of the portfolio, ranked #260.
Manulife (Manufacturers Life Insurance) first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $358M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Manulife (Manufacturers Life Insurance) held 147,961 shares of Regeneron Pharmaceuticals worth $92.3M as of Q2 2026.
- Manulife (Manufacturers Life Insurance) sold 260,970 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $178M.
- Regeneron Pharmaceuticals made up 0.07% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #260 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Manulife (Manufacturers Life Insurance)'s Regeneron Pharmaceuticals position peaked at $358M in Q2 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.